Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
This study has been completed.
Sponsor:
Duke University
Collaborators:
GlaxoSmithKline
Massachusetts General Hospital
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00215163
First received: September 20, 2005
Last updated: May 29, 2013
Last verified: September 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | June 2006 |
| Estimated Primary Completion Date: | No date given |
No publications provided by Duke University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):